- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Varian sells 4-T MR system for brain study
Varian announced that it is selling a very high field MR research system to McLean Hospital of Belmont, MA, the largest psychiatric teaching hospital for Harvard Medical School, for research into human brain function associated with drug abuse and
Varian announced that it is selling a very high field MR research system to McLean Hospital of Belmont, MA, the largest psychiatric teaching hospital for Harvard Medical School, for research into human brain function associated with drug abuse and psychiatric disorders.
Very high field (4-tesla) systems such as this one cost from $3 million to $4 million and are used only in research applications. In addition to its imaging capabilities, the Varian system can be used for in vivo nuclear MR spectroscopy, a technique for determining structural and functional relationships of chemical compounds in the brain.
Systems have also been ordered by the University of California, Berkeley; Emory University in Atlanta; and the National Institute for Environmental Studies in Tsukuba, Japan.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
